Walleye Capital
BPTH

Walleye Capital’s Bio-Path Holdings Inc BPTH Stock Holding History

Walleye Capital’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,462
Closed -$77.4K – 5677
2023
Q3 		$77.4K Buy
+10,462
New +$145K ﹤0.01% 4048
2023
Q2 		– Sell
-3,751
Closed -$104K – 5029
2023
Q1 		$104K Sell
3,751
-5,589
-60% -$201K ﹤0.01% 2905
2022
Q4 		$282K Buy
+9,340
New +$409K 0.01% 1836

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's BPTH Position: Q4 2023 in Review

Walleye Capital sold out of Bio-Path Holdings Inc (BPTH) in Q4 2023, closing a stake of 10,462 shares — an estimated $77.4K sold.

Walleye Capital first reported a position in BPTH in Q4 2022 and held it in 3 quarters. The position peaked at $282K in Q4 2022. 19 funds tracked by Wall St. Rank hold BPTH as of Q4 2023.

  • Walleye Capital reported no remaining Bio-Path Holdings Inc position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 10,462 Bio-Path Holdings Inc shares in Q4 2023, an estimated $77.4K.
  • Walleye Capital first reported a position in Bio-Path Holdings Inc in Q4 2022 and held it in 3 quarters.
  • Walleye Capital's Bio-Path Holdings Inc position peaked at $282K in Q4 2022.
  • 19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.